Citation Impact
Citing Papers
Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study
2017 Standout
Removing T-cell epitopes with computational protein design
2014 StandoutNobel
The mucin-selective protease StcE enables molecular and functional analysis of human cancer-associated mucins
2019 StandoutNobel
Randomized Double-Blind Placebo-Controlled Trial of Acetyl-L-Carnitine for the Prevention of Taxane-Induced Neuropathy in Women Undergoing Adjuvant Breast Cancer Therapy
2013
MUC1 Vaccine for Individuals with Advanced Adenoma of the Colon: A Cancer Immunoprevention Feasibility Study
2012
Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC) - gastrointestinal cancer group
2008
Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
2009 Standout
Estrogen receptor mutations and their role in breast cancer progression
2014
Gastric cancer
2016 Standout
A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA
2010
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
Myeloid-derived suppressor cells coming of age
2018 Standout
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
The relationship between numbness, tingling, and shooting/burning pain in patients with chemotherapy-induced peripheral neuropathy (CIPN) as measured by the EORTC QLQ-CIPN20 instrument, N06CA
2011
Chemotherapy-induced neuropathy: A comprehensive survey
2014
Oncology Meets Immunology: The Cancer-Immunity Cycle
2013 Standout
Breast cancer
2016 Standout
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Cell cycle proteins as promising targets in cancer therapy
2017 Standout
Further data supporting that paclitaxel‐associated acute pain syndrome is associated with development of peripheral neuropathy
2012
Phase II Trial of XELOX as First-Line Treatment for Patients with Advanced Gastric Cancer
2010
Association between patient reported outcomes and quantitative sensory tests for measuring long-term neurotoxicity in breast cancer survivors treated with adjuvant paclitaxel chemotherapy
2010
Definition and classification of cancer cachexia: an international consensus
2011 Standout
Beyond humanization and de-immunization: tolerization as a method for reducing the immunogenicity of biologics
2013
First-line treatment with oxaliplatin and capecitabine in patients with advanced or metastatic oesophageal cancer: a phase II study
2007
Chemotherapy-induced peripheral neurotoxicity (CIPN): An update
2011
Oxaliplatin in First-line Therapy for Advanced Non–Small-Cell Lung Cancer
2010
Molecular mechanisms of cisplatin resistance
2011 Standout
Delivery technologies for cancer immunotherapy
2019 Standout
Pharmacologic management of neuropathic pain: Evidence-based recommendations
2007 Standout
Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis
2014 Standout
The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments
2017
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
The use of combinations of monoclonal antibodies in clinical oncology
2015
Use of calcium and magnesium infusions in prevention of oxaliplatin induced sensory neuropathy
2010
A Good Drug Made Better: The Fulvestrant Dose-Response Story
2014
Crohn's disease
2016 Standout
Oesophageal carcinoma
2013 Standout
Amitriptyline in the Treatment of Chemotherapy-Induced Neuropathic Symptoms
2007
Cancer cachexia is associated with the IL10 −1082 gene promoter polymorphism in patients with gastroesophageal malignancy
2009
Role of bisphosphonates in postmenopausal women with breast cancer
2013
Management of aromatase inhibitor-associated bone loss in postmenopausal women with breast cancer: practical guidance for prevention and treatment
2011
Chemotherapy-induced peripheral neuropathy: Prevention and treatment strategies
2008
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Emerging Biological Principles of Metastasis
2017 Standout
Placebo Response Changes Depending on the Neuropathic Pain Syndrome: Results of a Systematic Review and Meta-Analysis
2012
Immune evasion of mantle cell lymphoma: expression of B7-H1 leads to inhibited T-cell response to and killing of tumor cells
2013
Ulcerative colitis
2016 Standout
Tumour-educated macrophages promote tumour progression and metastasis
2004 Standout
Dendritic-Cell-Based Therapeutic Cancer Vaccines
2013
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial
2012 Standout
Gastric cancer
2020 Standout
Pilot Trial of a Patient-Specific Cutaneous Electrostimulation Device (MC5-A Calmare®) for Chemotherapy-Induced Peripheral Neuropathy
2010
Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy
2013 Standout
Weekly docetaxel, cisplatin, and irinotecan (TPC): results of a multicenter phase II trial in patients with metastatic esophagogastric cancer
2009
Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a randomized, double-blind, placebo-controlled phase III trial
2011
A randomized phase II trial of platinum salts in basal-like breast cancer patients in the neoadjuvant setting. Results from the GEICAM/2006-03, multicenter study
2012
Therapeutic vaccines for cancer: an overview of clinical trials
2014
Cancer cachexia: A systematic literature review of items and domains associated with involuntary weight loss in cancer
2011
Gabapentin for chronic neuropathic pain and fibromyalgia in adults
2011
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
2010 Standout
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
2015 Standout
Treatment of Acute Lymphoblastic Leukaemia
2007
Clinical pharmacokinetics of tyrosine kinase inhibitors
2009
Liposomal drug delivery systems: From concept to clinical applications
2012 Standout
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
2014 Standout
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
2015
The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial
2010
Chemotherapy-Induced Peripheral Neuropathy: Prevention and Treatment
2011
The evidence for pharmacological treatment of neuropathic pain
2010
Burden of chemotherapy-induced neuropathy—a cross-sectional study
2010
Weight loss in patients with advanced cancer: effects, causes, and potential management
2008
Multicenter phase II study of capecitabine plus oxaliplatin as a first-line therapy in Chinese patients with advanced gastric cancer
2008
Overview of neuropathy associated with taxanes for the treatment of metastatic breast cancer
2015
Effect of calcium and magnesium on neurotoxicity and blood platinum concentrations in patients receiving mFOLFOX6 therapy: a prospective randomized study
2010
Discrepancy between the NCI-CTCAE and DEB-NTC scales in the evaluation of oxaliplatin-related neurotoxicity in patients with metastatic colorectal cancer
2011
Efficacy of lamotrigine in the management of chemotherapy‐induced peripheral neuropathy
2008
Macrophages Kill T9 Glioma Tumor Cells Bearing the Membrane Isoform of Macrophage Colony Stimulating Factor Through a Phagocytosis-Dependent Pathway
1998
SuFEx Click Chemistry Enabled Late-Stage Drug Functionalization
2018 StandoutNobel
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
Chemotherapy‐induced peripheral neurotoxicity: A critical analysis
2013
Interventions for preventing neuropathy caused by cisplatin and related compounds
2014
Pharmacological interventions for somatoform disorders in adults
2014 Standout
Nitric oxide and the immune response
2001 Standout
Elevated serum IL-10 levels in diffuse large B-cell lymphoma: a mechanism of aberrant JAK2 activation
2012
An Updated Understanding of the Mechanisms Involved in cHemotherapy-Induced Neuropathy
2018
Distinct Role of Macrophages in Different Tumor Microenvironments
2006 Standout
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
2016 Standout
Neuropathic Pain: From Mechanisms to Treatment
2020 Standout
NCCN Task Force Report: Management of Neuropathy in Cancer
2009
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
2014 Standout
Macrophages can recognize and kill tumor cells bearing the membrane isoform of macrophage colony-stimulating factor
1996
Phase III Randomized, Placebo-Controlled, Double-Blind Study of Intravenous Calcium and Magnesium to Prevent Oxaliplatin-Induced Sensory Neurotoxicity (N08CB/Alliance)
2013
Cancer treatment and survivorship statistics, 2016
2016 Standout
Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity
2014
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Recent Progress in GM-CSF-Based Cancer Immunotherapy
2017
Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
2014 Standout
Nitric oxide-producing CD11b+Ly-6G(Gr-1)+CD31(ER-MP12)+cells in the spleen of cyclophosphamide–treated mice: implications for T-cell responses in immunosuppressed mice
2000
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies
2015
Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index
2013 Standout
Phase I Study of the Aurora A Kinase Inhibitor Alisertib in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma: A NANT (New Approaches to Neuroblastoma Therapy) Trial
2016
Analysis of nanoparticle delivery to tumours
2016 Standout
The Tumor Microenvironment Innately Modulates Cancer Progression
2019 Standout
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
Role of calcium and magnesium infusion in prevention of oxaliplatin neurotoxicity. A phase III trial
2013
Emerging role of extracellular vesicles in mediating cancer cachexia
2018
Amitriptyline in the prevention of chemotherapy-induced neuropathic symptoms.
2009
Clinical Translation of Nanomedicine
2015
Natural History of Paclitaxel-Associated Acute Pain Syndrome: Prospective Cohort Study NCCTG N08C1
2011
Nitric oxide-producing CD11b+Ly-6G(Gr-1)+CD31(ER-MP12)+cells in the spleen of cyclophosphamide–treated mice: implications for T-cell responses in immunosuppressed mice
2000
Works of Daniel A. Nikcevich being referenced
Natural Killer Cell-Enriched Donor Lymphocyte Infusions from A 3-6/6 HLA Matched Family Member following Nonmyeloablative Allogeneic Stem Cell Transplantation
2010
The proteolysis-inducing factor: in search of its clinical relevance in patients with metastatic gastric/esophageal cancer
2006
A phase II trial of nab‐paclitaxel (ABI‐007) and carboplatin in patients with unresectable stage IV melanoma
2010
Docetaxel and capecitabine in patients with metastatic adenocarcinoma of the stomach and gastroesophageal junction: a phase II study from the North Central Cancer Treatment Group
2006
A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9)
2009
Stimulation of suppressor cells in the bone marrow and spleens of high dose cyclophosphamide-treated C57Bl/6 mice
1987
Phase II trial of two different irinotecan schedules with pharmacokinetic analysis in patients with recurrent glioma: North Central Cancer Treatment Group results
2008
Efficacy of gabapentin in the management of chemotherapy‐induced peripheral neuropathy
2007
Oxaliplatin and capecitabine in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction and gastric cardia: a phase II study from the North Central Cancer Treatment Group
2005
Fulvestrant in Women With Advanced Breast Cancer After Progression on Prior Aromatase Inhibitor Therapy: North Central Cancer Treatment Group Trial N0032
2006
Epratuzumab with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated diffuse large B-cell lymphoma
2011
Vaccination With Patient-Specific Tumor-Derived Antigen in First Remission Improves Disease-Free Survival in Follicular Lymphoma
2011
Intravenous Calcium and Magnesium for Oxaliplatin-Induced Sensory Neurotoxicity in Adjuvant Colon Cancer: NCCTG N04C7
2010
Stimulation of Hematopoiesis in Untreated and Cyclophosphamide Treated Mice by the Inhibition of Prostaglandin Synthesis
1986
Interleukin-1 genetic polymorphisms and their relationship to the cancer anorexia/weight loss syndrome in metastatic gastric and gastroesophageal junction adenocarcinoma.
2007
Evaluation of the effect of intravenous calcium and magnesium (CaMg) on chronic and acute neurotoxicity associated with oxaliplatin: Results from a placebo-controlled phase III trial
2009
N0338 phase II trial of docetaxel and carboplatin administered every two weeks as induction therapy for stage II or III breast cancer
2008
Elevated Serum Free Light Chains Are Associated With Event-Free and Overall Survival in Two Independent Cohorts of Patients With Diffuse Large B-Cell Lymphoma
2011
A phase III double blinded, placebo controlled, randomized trial of gabapentin in patients with chemotherapy-induced peripheral neuropathy: A North Central Cancer Treatment Group study
2005
Randomized Phase II Trial of Three Schedules of Pemetrexed and Gemcitabine As Front-Line Therapy for Advanced Non–Small-Cell Lung Cancer
2005
Immediate versus delayed zoledronic acid for prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen-N03CC
2009
Effect of intravenous calcium and magnesium (IV CaMg) on oxaliplatin-induced sensory neurotoxicity (sNT) in adjuvant colon cancer: Results of the phase III placebo-controlled, double-blind NCCTG trial N04C7
2008